Miguel Burgos

Profesor contratado doctor

Universidad de Navarra

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Miguel Burgos is a Profesor contratado doctor at Universidad de Navarra Facultad de Ciencias in Spain. His research primarily focuses on cancer biology and obesity, with recent publications exploring topics such as glucose transporters, immune targets in cancer, and specific mutations related to chronic pancreatitis. Additionally, his work includes investigating therapeutic strategies to overcome resistance in various breast cancer subtypes.

Articles (11)

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (9)

Pedro González-Muniesa

Profesor Titular

Universidad de Navarra

SPAIN

View details

Maria J. Moreno-Aliaga

Professor of Human Physiology

Universidad de Navarra

SPAIN

View details

Beatriz Domingo

Profesor Contratado Doctor Interino

University of Castilla-La Mancha

SPAIN

View details

Jose M. Arbones-Mainar

SPAIN

View details

Juan Llopis

Catedrático de Universidad / Professor

Universidad de Murcia Facultad de Medicina

SPAIN

View details

Maud Frieden

Université de Genève

SWITZERLAND

View details

Peter B. Stathopulos

Associate Professor

Western University

CANADA

View details

Eva M. Galán-Moya

University of Castilla-La Mancha

SPAIN

View details

Manuel Vicente Ruiz

Profesor Ayudante

Universidad de Castilla-La Mancha - Campus de Albacete

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Miguel Burgos

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

The glucose transporter GLUT12, a new actor in obesity and cancer

Maresin 1 Exerts a Tissue-Specific Regulation of Adipo-Hepato-Myokines in Diet-Induced Obese Mice and Modulates Adipokine Expression in Cultured Human Adipocytes in Basal and Inflammatory Conditions

Antitumoral Activity of a CDK9 PROTAC Compound in HER2-Positive Breast Cancer

Prognostic value of the immune target CEACAM6 in cancer: a meta-analysis

The p.E152K-STIM1 mutation deregulates Ca<sup>2+</sup> signaling contributing to chronic pancreatitis.

MZ1 co-operates with trastuzumab in HER2 positive breast cancer

Inhibition of the mitotic kinase PLK1 overcomes therapeutic resistance to BET inhibitors in triple negative breast cancer

Checkpoint kinase 1 pharmacological inhibition synergizes with dna-damaging agents and overcomes platinum resistance in basal-like breast cancer

Crocetin isolated from the natural food colorant saffron reduces intracellular fat in 3T3-L1 adipocytes

Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer

Pharmacological screening and transcriptomic functional analyses identify a synergistic interaction between dasatinib and olaparib in triple-negative breast cancer

Collaborators (9)

Pedro González-Muniesa

Maria J. Moreno-Aliaga

Beatriz Domingo

Jose M. Arbones-Mainar

Juan Llopis

Maud Frieden

Peter B. Stathopulos

Eva M. Galán-Moya

Manuel Vicente Ruiz

Make your next move.